C-reactive protein/oxidised low-density lipoprotein/β2-glycoprotein i complex promotes atherosclerosis in diabetic BALB/c mice via p38mitogen-activated protein kinase signal pathway

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Zhang, Rui ^a   Zhou, Sai Jun ^a   Li, Chun Jun ^a   Wang, Xiao Nan ^b   Tang, Yun Zhao ^a   Chen, Rui ^a   Lv, Lin ^a   Zhao, Qian ^a   Xing, Qiu Ling ^a   Yu, De Min ^a   Yu, Pei ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Children's Hospital   (China)

Author keywords

Atherosclerosis; BALB c mice; CRP oxLDL 2GPI complex; Diabetes; p38MAPK

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; BETA2 GLYCOPROTEIN 1; C REACTIVE PROTEIN; CYTOKINE; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 9; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; OXIDIZED LOW DENSITY LIPOPROTEIN; SOMATOMEDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; LIPID DIET; LIPID METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; AORTA; ATHEROSCLEROSIS; BETA 2-GLYCOPROTEIN I; C-REACTIVE PROTEIN; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIET, HIGH-FAT; GENE EXPRESSION REGULATION; LIPOPROTEINS, LDL; MACROPHAGES; MALE; MAP KINASE KINASE 3; MAP KINASE KINASE 6; MICE; MICE, INBRED BALB C; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; STREPTOZOCIN; T-LYMPHOCYTES;

MUS;

EID: 84875334150     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-42     Document Type: Article

References (34)

1. Postprandial hyperglycemia as an etiological factor in vascular failure. Node K, Inoue T, Cardiovasc Diabetol 2009 8 23 10.1186/1475-2840-8-23 19402896
2. Coronary-heart-disease risk and impaired glucose tolerance. Fuller JH, Shipley MJ, Rose G, The Whitehall study. Lancet 1980 1 1373 1376 (Pubitemid 10069461)
3. Impact of pre-diabetes and diabetes on cardiovascular outcomes. Anselmino M, Sillano D, Current Vascular Pharmacology 2012 10 6 680 683 10.2174/157016112803520882 23259552
4. Immunology of the antiphospholipid antibody syndrome. Roubey RAS, Arthritis Rheum 1996 39 1444 1456 10.1002/art.1780390903 8814055
5. A specific ligand for b 2-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macro-phages. Kobayashi K, Matsuura E, Liu Q, Furukawa J, Kaihara K, Inagaki J, Atsumi T, Sakairi N, Yasuda T, Voelker DR, J Lipid Res 2001 42 697 709 11352976 (Pubitemid 32507169)
6. The association of C-reactive protein with an oxidative metabolite of LDL and its implication in atherosclerosis. Tabuchi M, Inoue K, Usui-Kataoka H, Kobayashi K, Teramoto M, Takasugi K, Shikata K, Yamamura M, Ando K, Nishida K, Kasahara J, Kume N, Lopez LR, Mitsudo K, Nobuyoshi M, Yasuda T, Kita T, Makino H, Matsuura E, J Lipid Res 2007 48 4 768 781 10.1194/jlr.M600414-JLR200 17261875 (Pubitemid 46557882)
7. Lopez, Kazuko Kobaya shi, Yukana Matsun ami, Eiji Matsuura: Immunogenic Oxidized Low-density Lipoprotein/β2-glycoprotein I Complexes in the Diagnostic Management of Atherosclerosis. Luis R, Clinic Rev Allerg Immunol 2009 37 12 19 10.1007/s12016-008-8096-8
8. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J, J Hypertens 2002 20 2 159 169 10.1097/00004872-200202000-00001 11821696 (Pubitemid 34913777)
9. Review The role of adaptive T cell immunity in atherosclerosis. Mallat Z, Taleb S, Ait-Oufella H, Tedgui A, J Lipid Res 2009 50 364 9 19050311
10. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW, Arterioscler Thromb 1994 14 840 856 10.1161/01.ATV.14.5.840 8172861
11. Investigation of Sudan IV staining areas in aortas of infants and children: possible prelesional stages of atherogenesis. Torzewski M, Navarro B, Cheng F, Canisius A, Schmidt T, Bhakdi S, Urban R, Lackner KJ, Atherosclerosis 2009 206 159 167 10.1016/j.atherosclerosis.2009.01.038 19268943
12. Human IL-8 regulates smooth muscle cell VCAM-1 expression in response to endothelial cells exposed to atheroprone flow. Hastings NE, Feaver RE, Lee MY, Wamhoff BR, Blackman BR, Arterioscler Thromb Vasc Biol 2009 29 725 731 10.1161/ATVBAHA.109.184382 19229069
13. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D, J Clin Invest 1996 97 1715 1722 10.1172/JCI118598 8601637 (Pubitemid 26105480)
14. Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Landry DB, Couper LL, Bryant SR, Lindner V, Am J Pathol. 1997 151 1085 1095 9327742 (Pubitemid 27424318)
15. Lymphocytes and the adventitial immune response in atherosclerosis. Campbell KA, Lipinski MJ, Doran AC, Skaflen MD, Fuster V, McNamara CA, Circ Res 2012 110 6 889 900 10.1161/CIRCRESAHA.111.263186 22427326
16. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. Wang X, Collins HL, Ranalletta M, Fuki IV, Billheimer JT, Rothblat GH, Tall AR, Rader DJ, J Clin Invest 2007 117 2216 2224 10.1172/JCI32057 17657311 (Pubitemid 47219566)
17. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Meurs I, Lammers B, Zhao Y, Out R, Hildebrand RB, Hoekstra M, Van Berkel TJ, Van Eck M, Atherosclerosis 2012 221 1 41 47 10.1016/j.atherosclerosis.2011.11.024 22196936
18. Oxidized low-density lipoprotein-induced expression of abca1 in blood monocytes precedes coronary atherosclerosis and is associated with plaque complexity in hypercholesterolemic pigs. Geeraert B, De Keyzer D, Davey PC, Crombe F, Benhabiles N, Holvoet P, J Thromb Haemost 2007 5 2529 2536 10.1111/j.1538-7836.2007.02786.x 17922810 (Pubitemid 350154365)
19. SilversteinRL: CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. FebbraioM HDP, J clin Invest 2001 108 6 785 791 11560944
20. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. Acton SL, Scherer PE, Lodish HF, Krieger M, J Biol Chem 1994 269 33 21003 21009 7520436 (Pubitemid 24266467)
21. Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages. Liu Q, Kobayashi K, Furukawa J, Inagaki J, Sakairi N, Iwado A, Yasuda T, Koike T, Voelker DR, Matsuura E, J Lipid Res 2002 43 9 1486 1495 10.1194/jlr.M20063-JLR200 12235181
22. Circulating oxidized LDL forms complexes with b2-glycoprotein I: implication as an atherogenic autoantigen. Kobayashi K, Kishi M, Atsumi T, Bertolaccini ML, Makino H, Sakairi N, Yamamoto I, Yasuda T, Khamashta MA, Hughes GR, Koike T, Voelker DR, Matsuura E, J Lipid Res 2003 44 4 716 726 10.1194/jlr.M200329-JLR200 12562869 (Pubitemid 37279673)
23. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR, Prog Lipid Res 2006 45 6 466 486 10.1016/j.plipres.2006.05.001 16790279 (Pubitemid 44331411)
24. Philip Yu-An Ding, An-Na Chiang: Evidence for inhibition of low density lipoprotein oxidation and cholesterol accumulation by apolipoprotein H (b2- glycoprotein I). Lin K-Y, Pan J-P, Yang D-L, Huang K-T, Chang M-S, Life Sciences 2001 69 707 719 10.1016/S0024-3205(01)01164-X 11476192 (Pubitemid 32673629)
25. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Chang MK, Binder CJ, Torzewski M, Witztum JL, Proc Natl Acad Sci USA 2002 99 13043 13048 10.1073/pnas.192399699 12244213
26. Atherosclerosis- related functions of C-reactive protein. Agrawal A, Hammond DJ Jr, Singh SK, Cardiovasc Hematol Disord Drug Targets 2010 10 4 235 240 10.2174/187152910793743841 20932269
27. Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF- kappaB pathway. Sigala F, Savvari P, Liontos M, Sigalas P, Pateras IS, Papalampros A, Basdra EK, Kolettas E, Kotsinas A, Papavassiliou AG, Gorgoulis VG, J Cell Mol Med 2010 14 9 2273 2280 10.1111/j.1582-4934.2010.01082.x
28. A primer on cytokines: sources, receptors, effects, and inducers. Curfs JH, Meis JF, Hoogkamp-Korstanje JA, Clin Microbiol Rev 1997 10 742 780 9336671
29. The role of interleukin-1 in disease. Dinarello CA, Wolff SM, N Engl J Med 1993 328 106 113 10.1056/NEJM199301143280207 8439348
30. Tgf-beta induces il-9 production from human th17 cells. Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD, Orban T, Elyaman W, Khoury SJ, Kuchroo VK, Baecher-Allan C, Hafler DA, J Immunol 2010 185 46 54 10.4049/jimmunol.1000356 20498357
31. Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. Sachais BS, Kuo A, Nassar T, Morgan J, Kariko K, Williams KJ, Feldman M, Aviram M, Shah N, Jarett L, Poncz M, Cines DB, Higazi AA, Blood 2002 99 3613 3622 10.1182/blood.V99.10.3613 11986215 (Pubitemid 34534530)
32. Soluble N- cadherin overexpression reduces features of atherosclerotic plaque instability. Lyon CA, Johnson JL, Williams H, Sala-Newby GB, George SJ, Arterioscler Thromb Vasc Biol 2009 29 2 195 201 10.1161/ATVBAHA.108.178087 19008530
33. Lipid extract of Nostoc commune var. sphaeroides Kutzing, a blue-green alga, inhibits the activation of sterol regulatory element binding proteins in HepG2 cells. Rasmussen HE, Blobaum KR, Park YK, Ehlers SJ, Lu F, Lee JY, J Nutr 2008 138 476 481 18287352 (Pubitemid 351355243)
34. Transferrin-derived synthetic peptide induces highly conserved pro-inflammatory responses of macro phages. Haddad GF, Belosevic M, Mol Immunol 2009 46 4 576 586 10.1016/j.molimm.2008.07.030 18952294